Evidence map›Paper›PMID 31419285›Full record

ArticleThe Journal of infectious diseases2020

Tuberculosis Antigen-Specific T-Cell Responses During the First 6 Months of Antiretroviral Treatment.

Catherine Riou, Nishtha Jhilmeet, Molebogeng X Rangaka, Robert J Wilkinson, Katalin A Wilkinson

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Catherine RiouWellcome Center for Infectious Disease Research in Africa, University of Cape Town, South Africa.
Nishtha JhilmeetWellcome Center for Infectious Disease Research in Africa, University of Cape Town, South Africa.
Molebogeng X RangakaInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.
Robert J WilkinsonWellcome Center for Infectious Disease Research in Africa, University of Cape Town, South Africa.
Katalin A WilkinsonWellcome Center for Infectious Disease Research in Africa, University of Cape Town, South Africa.
University of Cape Town · ZA

Funding

Validation and Application of a Model for Human-like TB Latency in RabbitsU19AI111276 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI ALLAND, DAVID, ALLAND, DAVID · 2014 to 2020
$23.3M
Cancer Research UK FC001218Medical Research Council FC001218NIAID NIH HHS U19 AI111276Wellcome Trust 104803Wellcome Trust 106360Wellcome Trust 203135Wellcome Trust FC001218
6 · The paper itself

Abstract

The reconstitution of Mycobacterium tuberculosis antigen-specific CD4 T cells in a cohort of HIV-infected persons starting antiretroviral treatment (ART) in a high tuberculosis endemic area is described. Restoration of the antigen-specific CD4 T-cell subsets mirrored the overall CD4 T-cell compartment. Activation (assessed by HLA-DR expression) decreased during ART but remained elevated compared to HIV-uninfected persons. Despite known M. tuberculosis sensitization determined by interferon-γ release assay, 12/23 participants had no M. tuberculosis-specific CD4 T cells detectable by flow cytometry, combined with overall elevated T-cell activation and memory differentiation, suggesting heightened turnover. Our data suggest early ART initiation to maintain polyfunctional immune memory responses.

Indexed as

AdultAntigens, BacterialAnti-HIV AgentsCD4 Lymphocyte CountCD4-Positive T-LymphocytesFemaleFlow CytometryHIV InfectionsHLA-DR AntigensHumansImmunologic MemoryInterferon-gamma Release TestsLatent TuberculosisLymphocyte ActivationMaleMycobacterium tuberculosisAntigens, BacterialAnti-HIV AgentsHLA-DR Antigensantiretroviral treatmentimmune activationimmune reconstitutionprotectiontuberculosis

Identifiers

PMID31419285
PMCPMC6910879
OpenAlexW2968010992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.